Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Innovative Features and Safety Initiatives
    Innovative Features and Safety Initiatives World News
  • Women’s History Month: Science is for Everyone
    Women’s History Month: Science is for Everyone Business
  • War Day 142: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych  & #Feygin
    War Day 142: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • FAA Halts Boeing MAX Production Expansion to Improve Quality Control, Also Lays Out Extensive Inspection and Maintenance Process to Allow Boeing 737-9 MAX Aircraft to Return to Service
    FAA Halts Boeing MAX Production Expansion to Improve Quality Control, Also Lays Out Extensive Inspection and Maintenance Process to Allow Boeing 737-9 MAX Aircraft to Return to Service Aviation
  • The Mosque Bombing in Peshawar, Pakistan
    The Mosque Bombing in Peshawar, Pakistan World News
  • Fortun / Luminar Media Group Announces Debt Restructuring to Minimize Legacy Debt and Maximize Shareholder Value
    Fortun / Luminar Media Group Announces Debt Restructuring to Minimize Legacy Debt and Maximize Shareholder Value Business
  • AUVSI Announces SolidIntel as New Supply Chain Monitoring Partner for Green UAS
    AUVSI Announces SolidIntel as New Supply Chain Monitoring Partner for Green UAS Aviation
  • PURCHASE OF SHARES & SHARE REPURCHASE PROGRAM, ENHANCEMENT OF AGILITY BUSINESS MODEL, ISSUANCE OF OPTIONS TO CEO
    PURCHASE OF SHARES & SHARE REPURCHASE PROGRAM, ENHANCEMENT OF AGILITY BUSINESS MODEL, ISSUANCE OF OPTIONS TO CEO World News
GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China

GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China

Posted on March 20, 2023 By NewsEditor
GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in ChinaGB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in ChinaAccording to Statista, China has the second largest pharmaceutical market in the world and plant-based medicines are very well accepted, which makes China a potential target market for Gb Sciences.

GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China
Patent


LAS VEGAS, March 20, 2023 (Newswire.com) - Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has recently been issued a patent in China to protect its proprietary cannabinoid-containing formulation for the treatment of Parkinson's disease. China is an increasingly important pharmaceutical market with cultural acceptance of plant-based formulations, which is a good fit for Gb Sciences' drug candidates. Gb Sciences' first international patent also confirms that the Company's intellectual property strategy can work globally and strengthens the Company's patent portfolio. The global market for treatments of Parkinson's disease is projected to grow to $8.8 billion by the year 2026, and new therapies to address Parkinson's disease symptoms are greatly needed.

"The issuance of Gb Sciences' first international patent protecting methods of using our proprietary cannabinoid-containing formulations for treating Parkinson's disease is an important milestone in the development of these vitally important therapies. Gb Sciences' recent patent issued in China validates both our plant-inspired drug discovery process and intellectual property strategy, which involve defining and protecting Minimum Essential Mixtures," explained Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences, Inc. "Gb Sciences starts its drug discovery process with plant-based therapies that are working anecdotally or in traditional medical systems, then we systematically reduce the number of compounds to reveal Minimum Essential Mixtures. Gb Sciences' novel Minimum Essential Mixtures retain the increased efficacy of whole plant medicines, but they are easier to manufacture with precision at scale like single ingredient drugs. These Minimum Essential Mixtures are a viable alternative to standard single ingredient drugs or traditional whole plant medicines."

Gb Sciences' Minimum Essential Mixture-based drug development strategy does not aim to treat complex diseases as if they were caused by a single factor, but instead addresses the combination of factors that lead to a complex human disorder. Minimum Essential Mixtures (MEMs) are potentially more effective than single ingredient drugs because the different active ingredients target the multiple human processes responsible for complex diseases, such as neurodegeneration, heart disease, and cancers. As such, MEMs may offer a more holistic treatment for complex disorders such as Parkinson's disease that cannot be attributed to a single cause, while maintaining the manufacturing and quality control advantages of single ingredient drugs.

Gb Sciences' patent portfolio currently contains six issued U.S. and four issued foreign patents, as well as 15 U.S. and 49 foreign patent-pending applications that cover our novel AI-enabled drug discovery platform and proprietary plant-inspired therapies for more than 65 different disorders. 

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The 'plant-inspired' active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences' intellectual property portfolio contains six issued U.S. and four issued foreign patents, as well as 15 U.S. and 49 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences' lead program for Parkinson's disease is being prepared for a first-in-human clinical trial. Gb Sciences' formulations for chronic pain, anxiety and depression are currently in preclinical animal studies with researchers at the National Research Council of Canada (NRC). The company also received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome, and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. Gb Sciences' productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Contact Information:
Alexis Quintal
[email protected]


Original Source: GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China

The post GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China first appeared on Social Gov.

Business

Post navigation

Previous Post: War Day 220: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
Next Post: War Day 219: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin

Related Posts

  • DerScanner Participates in Delphi Day Italy to Support Local Developer Community
    DerScanner Participates in Delphi Day Italy to Support Local Developer Community Business
  • Breast Cancer Liquid Biopsy Market Is Projected To Reach 7.05 Million by 2027
    Breast Cancer Liquid Biopsy Market Is Projected To Reach $357.05 Million by 2027 Business
  • mxHERO Announces Generative AI for Mail2Cloud Unlocking Valuable Insights for Enterprise Email
    mxHERO Announces Generative AI for Mail2Cloud Unlocking Valuable Insights for Enterprise Email Business
  • Love Sigma Solidifies Position as Premier Relationship Resource with Acquisition of Impett Relationships Labs
    Love Sigma Solidifies Position as Premier Relationship Resource with Acquisition of Impett Relationships Labs Business
  • Career Certified Acquires A.D. Banker, the Industry Leader in Pre-Licensing and Continuing Education for Insurance and Securities Professionals
    Career Certified Acquires A.D. Banker, the Industry Leader in Pre-Licensing and Continuing Education for Insurance and Securities Professionals Business
  • California Intercontinental University Celebrates Student Achievement Through Inspiring Webinar on Purpose and Meaning
    California Intercontinental University Celebrates Student Achievement Through Inspiring Webinar on Purpose and Meaning Business
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Franchise Development Service Market to Reach USD $10.94 Billion by 2029 at 9.4% CAGROctober 9, 2025
  • Financial Outsourcing Services Market to Reach $74.72 Billion by 2029 with 8.3% CAGROctober 8, 2025
  • Fairhope Aerospace Earns SBA Veteran-Owned Small Business CertificationOctober 8, 2025
  • Experience Ibogaine Contributes to Ongoing Research on Ibogaine’s Interactions with the BodyOctober 1, 2025
  • Financial Grade Security Chip Global Market Report 2025| Business Growth, Current and Future Trends till 2029October 1, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • U.S. Mint Presents its New Bessie Coleman Commemorative Quarter to the FAA
    U.S. Mint Presents its New Bessie Coleman Commemorative Quarter to the FAA Aviation
  • Corinium Global Intelligence Announces CDAO Fall 2025 in Boston, MA
    Corinium Global Intelligence Announces CDAO Fall 2025 in Boston, MA Business
  • Johnson County’s Residential Properties Have Seen A Remarkable 12.6% Jump In The 2024 Reassessment!
    Johnson County’s Residential Properties Have Seen A Remarkable 12.6% Jump In The 2024 Reassessment! Business
  • Otto Aviation Announces New Manufacturing Facility and Headquarters in Jacksonville, Florida
    Otto Aviation Announces New Manufacturing Facility and Headquarters in Jacksonville, Florida Aviation
  • As Australia’s Rising Cost of Living Impacts Consumer Behaviour, Digital Marketing Experts Weigh in on What This Means for Businesses
    As Australia’s Rising Cost of Living Impacts Consumer Behaviour, Digital Marketing Experts Weigh in on What This Means for Businesses Business
  • Anytron Unveils Fully Digital Label Print to Finish Inline
    Anytron Unveils Fully Digital Label Print to Finish Inline World News
  • Legendary Icon Jimi Hendrix Foundation Launches Its First Ever Experiential Crypto Token: $HEYJOE
    Legendary Icon Jimi Hendrix Foundation Launches Its First Ever Experiential Crypto Token: $HEYJOE World News
  • War in Ukraine, Analytics. Day 943: Zelensky’s Peace Plan. Is it Victory or Not Yet? Arestovych
    War in Ukraine, Analytics. Day 943: Zelensky’s Peace Plan. Is it Victory or Not Yet? Arestovych World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .